Dell Medical School

What Dell Medical School does

Dell Medical School is a public academic medical school within The University of Texas at Austin that trains physician leaders, conducts biomedical and translational research, and delivers patient care through its clinical practice, UT Health Austin. The school's core operations span an M.D. program, multiple graduate medical education residencies and fellowships (Emergency Medicine, Orthopaedic Surgery, General Surgery, Geriatric Psychiatry, Pediatric Emergency Medicine, Surgical Critical Care), and a continuing medical education arm — all built around an Advancing Care Transformation (ACT) curriculum emphasizing value-based care, quality improvement, equity, leadership, and teamwork. Clinical training and care are delivered in partnership with Ascension Seton (including Dell Seton, a Level I Trauma Center), Austin State Hospital, Caraday Healthcare, and other Central Texas sites.

Dell Med runs a diversified revenue model anchored in tuition and fees, federal and industry-sponsored research grants (including a $27.2M NIA-funded ReCARDO Alzheimer's data-harmonization program and an $11.6M DoD-funded SAINT neuromodulation postpartum-depression trial), and clinical practice revenue from UT Health Austin. Research is concentrated in musculoskeletal care, multiple sclerosis (via the multi-site MSIN network with MSAA, Novartis, and Genentech), translational AI and informatics (new Department of Quantitative and Systems Health Sciences), women's health, and surgical specialties. The school also operates commercialization and entrepreneurship programming (Texas Health CoLab, The Impact Factory, annual Innovation Week) and co-developed the Lancet-published Joint Insights AI decision-support tool with OM1, signaling an emerging applied AI product surface beyond pure research output.

Name

Dell Medical School

Legal name

Dell Medical School at The University of Texas at Austin

Website

https://dellmed.utexas.edu

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Short description

Dell Medical School is a public academic medical school at The University of Texas at Austin that trains physician leaders, runs multi-site clinical research, and delivers patient care through UT Health Austin in Central Texas.

Ownership category

akta.pro rank

Product category

Academic Medical Education

NAICS

Colleges, Universities, and Professional Schools (6113), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Medical education
• Graduate medical training
• Clinical patient care
• Biomedical research
• Academic medicine

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Education Programs: Revenue from tuition, fees, and educational programs including M.D. program, residencies, fellowships, and continuing medical education
2. Research Grants and Funding: Federal and private research funding including NIH grants, Department of Defense funding for clinical trials, and industry-sponsored research agreements
3. Patient Care Services: Clinical care revenue through UT Health Austin, the clinical practice of Dell Medical School, providing medical services to patients in Central Texas

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Dell Medical School is an academic medical institution at The University of Texas at Austin that delivers undergraduate medical education (M.D. Program), graduate medical education (residencies and fellowships across multiple specialties), and clinical patient care through its UT Health Austin practice. It also conducts biomedical and translational research (including AI-driven decision support tools and neuromodulation therapy trials) and supports healthcare innovation and entrepreneurship via programs such as Texas Health CoLab and The Impact Factory.

Product overview

Dell Medical School is an academic medical institution at The University of Texas at Austin offering medical education through its M.D. Program, multiple graduate medical education residencies and fellowships, and clinical care via UT Health Austin. The school provides AI-powered decision support tools (Joint Insights) for clinical applications, and supports innovation through programs like the Texas Health CoLab and The Impact Factory. Educational offerings include the Advancing Care Transformation (ACT) curriculum for residents and continuing medical education programs.

Differentiator

Problem solved

Functional benefit

Products and services

• M.D. Program Medical degree program training future physician leaders to tackle systemic challenges in health, featuring a curriculum focused on 21st-century health and medicine for prospective medical students.
• Graduate Medical Education (Residencies & Fellowships) Multiple residency and fellowship programs including Emergency Medicine, Orthopaedic Surgery, General Surgery, Geriatric Psychiatry, Pediatric Emergency Medicine, and Surgical Critical Care, featuring the Advancing Care Transformation (ACT) curriculum for resident physicians.
• UT Health Austin Clinical Practice Clinical practice providing person-centered, multidisciplinary patient care through multiple specialty clinics including Musculoskeletal Institute, Comprehensive Memory Center, Heartburn and Esophageal Disorders Center, Surgical Oncology, and Abdominal Transplant Center for patients in Central Texas.
• Joint Insights AI-Powered Decision Support Tool AI-powered clinical decision support tool developed in collaboration with OM1 that improves treatment decision quality and patient outcomes for knee osteoarthritis patients, with results published in The Lancet.
• Texas Health CoLab Innovation initiative supporting entrepreneurship and commercialization of health technologies and innovations developed by UT Austin researchers and partners.
• The Impact Factory Program cultivating a culture of life sciences innovation, supporting startup companies and providing entrepreneurial training for doctors, researchers, and students.
• ReCARDO Research Initiative $27.2 million National Institute on Aging initiative led by Hongfang Liu and Dell Medical School focused on harmonizing real-world clinical data to advance Alzheimer's disease and dementia research across 10 leading institutions.
• SAINT Neuromodulation Therapy Postpartum Depression Clinical Trial $11.6 million Department of Defense-funded pivotal clinical trial led by Dell Medical School as a site evaluating Magnus Medical's SAINT neuromodulation therapy (an FDA-cleared non-invasive brain stimulation therapy) for postpartum depression, enrolling up to 192 women across four leading research institutions.
• Multiple Sclerosis Implementation Network (MSIN) Practice-based research network connecting MS care centers throughout the United States (in collaboration with pharmaceutical companies, MSAA, and technology partner SEQSTER) to share data and insights to improve care and outcomes for people living with multiple sclerosis; expanded to over 1,000 participants across 20 sites nationwide.
• Health Sciences Summer Camps Summer day camps for middle and high school students in Central Texas providing hands-on science experiments and interaction with health professionals, with virtual camp tuition at $200 per student and full/partial scholarships available.

Quantifiable outcome

• AI-powered Joint Insights decision support tool improves treatment decision quality and patient outcomes for knee osteoarthritis patients (published in The Lancet)
• +2 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Multiple Sclerosis Association of America (MSAA)coreStrategic or Co-development Partner · 28 May 2026MSIN is a practice-based research network connecting MS care centers throughout the United States to share data and insights to improve care and outcomes for people living with multiple sclerosis. Dell Medical School collaborates with MSAA, healthcare institutions, and pharmaceutical companies on this patient-driven research collaboration.
• UTHealth HoustoncoreStrategic or Co-development Partner · 28 May 2026Healthcare institution partner in the Multiple Sclerosis Implementation Network (MSIN) research initiative involving over 1,000 participants across 20 sites
• Novartis Pharmaceuticals CorporationcoreStrategic or Co-development Partner · 28 May 2026Pharmaceutical company collaborating on MSIN research initiative to improve care and outcomes for people living with multiple sclerosis
• GenentechcoreStrategic or Co-development Partner · 28 May 2026Pharmaceutical company collaborating on MSIN research initiative to improve care and outcomes for people living with multiple sclerosis
• SEQSTERcoreTechnology or Integration · 28 May 2026Technology partner for MSIN research initiative providing data integration capabilities across multiple care centers
• Mayo CliniccoreStrategic or Co-development Partner · 18 May 2026Partner institution for ReCARDO $27.2M National Institute on Aging initiative focused on harmonizing real-world clinical data to advance Alzheimer's disease and dementia research across 10 leading institutions. Hongfang Liu brings experience from Mayo Clinic in biomedical informatics and translational AI.
• DellminorStrategic or Co-development Partner · 7 May 2026Industry partner featured at Innovation Week 2026 exploring the future of Central Texas's expanding economy
• GoogleminorStrategic or Co-development Partner · 7 May 2026Industry partner featured at Innovation Week 2026 exploring the future of Central Texas's expanding economy
• NeuralinkminorStrategic or Co-development Partner · 7 May 2026Industry partner featured at Innovation Week 2026 exploring the future of Central Texas's expanding economy
• Mursla BiominorStrategic or Co-development Partner · 5 March 2026Provides operational guidance to Mursla Bio through ABHI US Accelerator program, supporting introduction of EvoLiver liver cancer surveillance test to US market with structured access to healthcare leaders
• Association of British HealthTech Industries (ABHI)minorStrategic or Co-development Partner · 5 March 2026Participates in ABHI US Accelerator program providing structured access to over 300 senior healthcare leaders across 35 hospitals, 20 health systems, and US insurers
• Becton DickinsonminorStrategic or Co-development Partner · 5 March 2026Operational guidance partner in ABHI US Accelerator program for Mursla Bio's EvoLiver test introduction
• Magnus MedicalcoreStrategic or Co-development Partner · 5 February 2026Clinical trial site for Magnus Medical's $11.6M DoD-funded pivotal clinical trial evaluating SAINT neuromodulation therapy for postpartum depression. Trial enrolls up to 192 women across four leading research institutions.
• University of Massachusetts Chan Medical SchoolcoreStrategic or Co-development Partner · 5 February 2026Multi-site clinical trial partner for SAINT neuromodulation therapy study, enrolling first patient at UMass Chan
• Medical University of South CarolinacoreStrategic or Co-development Partner · 5 February 2026Multi-site clinical trial partner for SAINT neuromodulation therapy study for postpartum depression
• Icahn School of Medicine at Mount SinaicoreStrategic or Co-development Partner · 5 February 2026Multi-site clinical trial partner for SAINT neuromodulation therapy study for postpartum depression
• OM1coreStrategic or Co-development Partner · 10 December 2025Joint development of AI-powered decision support tool Joint Insights for knee osteoarthritis patients. Clinical trial published in The Lancet demonstrates improved decision quality and patient outcomes.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Icahn School of Medicine at Mount Sinai: Research-intensive MD-granting school with strength in neuromodulation, AI in medicine, and clinical trials. Direct peer on translational research programs and an active multi-site trial partner with Dell Med on SAINT neuromodulation.
• Texas A&M University School of Medicine: Public Texas MD-granting medical school with distributed campus model. Direct peer on public institutional structure, GME programs, and competition for in-state applicants and research funding.
• McGovern Medical School at UTHealth Houston: Another public UT System MD-granting medical school with a large academic medical center in Texas. Directly comparable on academic structure, public funding model, and partner status with Dell Med in research networks like ReCARDO.
• Baylor College of Medicine: Private MD-granting medical school in Houston with a top-tier academic medical center and large research portfolio. Direct peer on training physician leaders and competing for Texas-based medical talent and research funding.
• Mayo Clinic Alix School of Medicine: Research-intensive MD-granting school embedded in a major AMC, with strong AI/biomedical informatics and a Translational AI track. Direct peer on translation-focused curriculum and an active collaboration partner (ReCARDO) of Dell Med.
• UMass Chan Medical School: Public MD-granting medical school with notable strength in translational research and clinical trials. Direct peer on GME structure and active multi-site trial partner with Dell Med on SAINT neuromodulation therapy.
• Long School of Medicine at UT Health San Antonio: Public UT System MD-granting medical school in San Antonio. Direct peer on public funding model, GME offerings, and Central/South Texas patient catchments; competes for clinical research partnerships and faculty.
• UT Southwestern Medical School: Public Texas medical school within the UT System, MD-granting, with a major academic medical center and substantially larger NIH funding base. Directly comparable in mission and geographic-tertiary-catchment competition for Texas talent and patients.

Broad incumbents

• UCSF School of Medicine: Top-tier research MD-granting school with leadership in value-based care and orthopedic surgery (the previous home of Dell Med's Surgery Chair, Kevin Bozic). Comparable on training physician leaders and value-based care, but materially larger in scale and reputation.
• Stanford School of Medicine: Elite research-intensive MD-granting school with strong AI-in-medicine and medical innovation programs. Comparable to Dell Med on innovation/entrepreneurship curriculum but with a far larger brand, endowment, and funding base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dell Medical School